VentureMed Group

Founded in 2012, the VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts. The Flex Vessel Prep System facilitates an ideal environment for treating PAD and AV fistulas and grafts by safely creating linear, parallel micro-incisions in plaque of any length to deliver acute lumen gain and vessel compliance enabling better clinical outcome for patients. The true vessel prep FLEX technology is currently indicated for use in femoral and popliteal arteries and restoring access to AV fistulas and grafts. The FLEX Vessel Prep System received CE Mark in 2015 and 510(k) clearance from the US Food and Drug Administration in 2016.